BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 1700077)

  • 1. Treatment of testicular cancer: a new and improved model.
    Einhorn LH
    J Clin Oncol; 1990 Nov; 8(11):1777-81. PubMed ID: 1700077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of disseminated germ cell tumors.
    Einhorn LH
    Cancer; 1987 Aug; 60(3 Suppl):570-3. PubMed ID: 2439185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
    Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
    J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of chemotherapy and salvage surgery for advanced testicular cancer].
    Saiki S; Meguro N; Maeda O; Kinouchi T; Kuroda M; Usami M; Kotake T; Miki T
    Hinyokika Kiyo; 1999 Nov; 45(11):777-81. PubMed ID: 10637743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential trials of cisplatin, vinblastine, and bleomycin and etoposide and cisplatin in disseminated nonseminomatous germ cell tumors of the testis with a good prognosis at a single institution.
    Germá JR; Sagarra AF; Izquierdo MA; Seguí MA
    Cancer; 1993 Feb; 71(3):796-803. PubMed ID: 7679314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
    Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
    Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results.
    Pizzocaro G; Salvioni R; Piva L; Faustini M; Nicolai N; Gianni L
    Ann Oncol; 1992 Mar; 3(3):211-6. PubMed ID: 1316779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for favorable outcome in disseminated germ cell tumors.
    Birch R; Williams S; Cone A; Einhorn L; Roark P; Turner S; Greco FA
    J Clin Oncol; 1986 Mar; 4(3):400-7. PubMed ID: 2419524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
    Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J
    Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial.
    Loehrer PJ; Johnson D; Elson P; Einhorn LH; Trump D
    J Clin Oncol; 1995 Feb; 13(2):470-6. PubMed ID: 7531223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin.
    Stoter G; Vendrik CP; Struyvenberg A; Sleyfer DT; Vriesendorp R; Schraffordt Koops H; van Oosterom AT; ten Bokkel Huinink WW; Pinedo HM
    Cancer; 1984 Oct; 54(8):1521-4. PubMed ID: 6206937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testicular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patients.
    Göbel U; Calaminus G; Haas R; Teske C; Schönberger S; Schneider DT; Leuschner I; Harms D
    Klin Padiatr; 2014 Nov; 226(6-7):316-22. PubMed ID: 25431864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curing metastatic testicular cancer.
    Einhorn LH
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4592-5. PubMed ID: 11904381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A randomized trial of PVB, VAB-6, BVP regimen versus PEB chemotherapy in patients with disseminated testicular tumors].
    Fukui I; Komatsubara S; Akaza H; Sakashita S; Akasaka Y; Tobisu K; Yamauchi T; Deguchi N; Furuhata A; Kawai T
    Nihon Hinyokika Gakkai Zasshi; 1991 Jun; 82(6):976-83. PubMed ID: 1715416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of metastatic seminoma by chemotherapy.: an experience].
    Komatsubara S; Itoi T; Watanabe M; Kitamura Y; Koike T
    Nihon Hinyokika Gakkai Zasshi; 2000; 91(10-11):666-72. PubMed ID: 11109817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.
    Einhorn LH; Williams SD; Loehrer PJ; Birch R; Drasga R; Omura G; Greco FA
    J Clin Oncol; 1989 Mar; 7(3):387-91. PubMed ID: 2465391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer.
    Loehrer PJ; Einhorn LH; Williams SD
    J Clin Oncol; 1986 Apr; 4(4):528-36. PubMed ID: 3633952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group.
    Levi JA; Raghavan D; Harvey V; Thompson D; Sandeman T; Gill G; Stuart-Harris R; Snyder R; Byrne M; Kerestes Z
    J Clin Oncol; 1993 Jul; 11(7):1300-5. PubMed ID: 7686216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: the Institut Gustave Roussy experience.
    Farhat F; Culine S; Théodore C; Békradda M; Terrier-Lacombe MJ; Droz JP
    Cancer; 1996 Mar; 77(6):1193-7. PubMed ID: 8635143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testicular cancer: an oncological success story.
    Einhorn EH
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2630-2. PubMed ID: 10068265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.